Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.34 -0.07 (-4.96%)
At close: Nov 11, 2026 · 4:00 PM EST

Tvardi Therapeutics (TVRD) Price to Earnings (2020 - 2021)

Updated

Tvardi Therapeutics' (TVRD) Price to Earnings came in at 32.50 for Q3 2021, down 62.0% from the prior quarter.

Analysis

Tvardi Therapeutics (TVRD) Price to Earnings (2020 - 2021) Analysis & Trends

For FY2020, Tvardi Therapeutics' Price to Earnings stood at 89.72.

  • According to Business Quant data, Price to Earnings for the three prior quarters was 85.55 (Q2 2021), 77.40 (Q1 2021) and 89.72 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Tvardi Therapeutics 13.23 Mn -94.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 32.50
Jun 30, 2021 85.55
Mar 31, 2021 77.40
Dec 31, 2020 89.72
API Access

Tvardi Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=TVRD&period=max&api_key=YOUR_API_KEY